Skip to content
sellWeak cluster of 610b5-1 plan

Linda Llewelyn sold $51k of HCAT

Chief People Officer at Health Catalyst, Inc.. 6,442 shares at an average of $7.88, traded Dec 16, 2024, filed Dec 18, 2024.

Warning score
17
Value
$51k
6,442 shares
Holdings after
98,702
-6% from before
From 52-week low
+7%
low $7.36, close $7.85
From 52-week high
-13%
high $9.02, as of Dec 16, 2024

Score components

  • Role
    Officer
    +15
  • Trade size
    $51k at market
    +7
  • Share of holdings sold
    Sold 6.1% of holdings
    0
  • Cluster
    6 insiders selling within 14 days
    +15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -24.5%, 3m -38.0%, 6m -49.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

HCATOct 13, 2026 · close 1.74
Since filing Dec 18, 2024: -76.1%SPY +35.8% · excess -111.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001562180-24-008480, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 16, 2024SOpen-market sale
Common Stock10b5-1
-6,442$7.88$51k98,702Dec 18, 2024

Related signals

Other insiders at Health Catalyst, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
43Moderate
HCATbuy
Health Catalyst, Inc.
Simeon Kohl
Chief Executive Officer
$105k
59,000 shares
+2%
44Moderate
HCATsell 2
Health Catalyst, Inc.
Julie Larson-Green
director
$128k
47,997 shares
-39%
16Weak
HCATsell 210b5-1
Health Catalyst, Inc.
Benjamin Landry
General Counsel
$72k
27,425 shares
-22%
0Weak
HCATsell10b5-1
Health Catalyst, Inc.
Benjamin Landry
General Counsel
$21k
6,175 shares
-4%
0Weak
HCATsell10b5-1
Health Catalyst, Inc.
Benjamin Landry
General Counsel
$24k
6,057 shares
-4%
0Weak
HCATsell10b5-1
Health Catalyst, Inc.
Daniel LeSueur
Chief Operating Officer
$21k
5,209 shares
-2%
0Weak
HCATsell10b5-1
Health Catalyst, Inc.
Daniel LeSueur
Chief Operating Officer
$22k
5,209 shares
-2%
16Weak
HCATsell 210b5-1
Health Catalyst, Inc.
Daniel LeSueur
Chief Operating Officer
$76k
16,902 shares
-7%
11Weak
HCATsell 210b5-1
Health Catalyst, Inc.
Benjamin Landry
General Counsel
$63k
13,827 shares
-8%
9Weak
HCATsell 210b5-1
Health Catalyst, Inc.
Linda Llewelyn
Chief People Officer
$35k
6,441 shares
-7%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Linda Llewelyn sold $51k of HCAT | InsiderTell